Newsletter | April 13, 2026

04.13.26 -- Old Habits, Communication Issues Still Stalling Site Budget Negotiations

SPONSOR

Clinical trials should be simpler for both patients and sponsors. Trialmed brings a patient first approach to research by combining a global site network with flexible solutions that improve recruitment engagement and retention. By reducing barriers through digital tools and bringing studies closer to patients Trialmed helps drive more inclusive participation and stronger outcomes. Better trials start with a better experience for every patient.

PATIENT CENTRICITY

Patient-Powered Drug Trials Are Getting The FDA Greenlight

Patient- and parent-led drug development is on the rise, with the latest effort securing FDA clearance for a gene therapy trial. Yet, they are largely invisible. Buffalo Initiative plans to change that.

Overcome Patient-Level Access Barriers For New Medicine

Explore market access from the patient’s perspective and identify five aspects of how people get hold of medicine that should inform commercialization.

Trial Participant Tax Compliance Is A Serious Burden — Make It Ours

Learn how strategic payment structures can reduce tax exposure for participants, protect benefit eligibility, and simplify global operations.

Therapeutic Experience: Supporting Recruitment And Retention

CSSi offers customized patient recruitment and retention solutions across the globe, ensuring successful enrollment for clinical trials across various therapeutic areas.

SPONSOR

Smart Sourcing: Patient Recruitment & Retention Showcase, a virtual event for clinical teams to explore and compare top patient recruitment and engagement partners. Expect live, side-by-side comparisons, real-time Q&A, and practical insights to boost enrollment, diversity, and retention. Ideal for Clinical Ops, Site Engagement, and Vendor Management teams. Leave with a vetted shortlist of partners and actionable takeaways—without the time, cost, or travel of traditional conferences.

PATIENT RECRUITMENT

How The ACA Subsidy Lapse Could Hurt Clinical Trial Enrollment

The relationship between the Affordable Care Act (ACA) enhanced premium subsidies and clinical research isn’t widely understood, so consultant Devra Densmore is clearing things up, including how coverage loss could impact trial enrollment.

How To Reduce Eligibility Risk And Prevent Protocol Deviations

Eliminate enrollment-based protocol deviations and align with the latest FDA guidance by implementing a centralized, technology-enabled eligibility review to safeguard trial integrity.

Global E-Consent Matrix

Navigate complex regional regulations and identity requirements to modernize your global clinical trial enrollment. Ensure compliance and access while moving toward digital participant engagement.

DCT Solutions That Successfully Deliver Results

Catch MRN's COO speaking on the impact DCT/hybrid trial design can have on overall trial success, noting that there is no "one-size-fits-all" — it takes a tailored approach to achieve maximum results.

CLINICAL SITES

Old Habits, Communication Issues Still Stalling Site Budget Negotiations

Drawing from the 2025 SCRS Landscape Survey Report, Jimmy Bechtel and Ken Getz unpack how growing trial complexity, inconsistent fair market value benchmarks, and structural disconnects are reshaping site-sponsor relationships.

The Promise Of IQVIA One Home For Sites: A Site CEO's Perspective

By providing research sites with a unified, streamlined interface, we can reduce operational friction, enhance collaboration, and ultimately accelerate the development of new therapies.

Early Engagement With Sites: Timing Matters More Than Tools

Involving sites earlier in study planning changes how trials unfold. This piece explores how timing influences alignment, execution, and day-to-day delivery across the clinical research lifecycle.

Challenges That Derail Bladder Cancer Trials And How To Anticipate Them Earlier

From the rapid evolution of standard-of-care benchmarks to the logistical strain of procedure-heavy urology workflows, the path to a successful endpoint is filled with operational friction.

Your Trial Is In Jeopardy. Time Is Critical.

Expert ophthalmic teams rescue clinical trials with stabilized studies, nationwide coverage, and eye assessments, helping protect endpoints and regain timeline control quickly.

CHOOSE YOUR OWN ADVENTURE

You're receiving the Monday edition of the Clinical Leader newsletter, focusing on Clinical SitesPatient Centricity, and Patient Recruitment. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: